Literature DB >> 11488598

Cationic liposomes induce macrophage apoptosis through mitochondrial pathway.

Y Aramaki1, S Takano, S Tsuchiya.   

Abstract

To clarify the mechanism of apoptosis of the macrophage-like cell line RAW264.7 induced by cationic liposomes, we focused on the mitochondria and investigated the changes in mitochondrial membrane potential and the release of cytochrome c following treatment of cationic liposomes composed of stearylamine (SA-liposomes). SA-liposomes induced mitochondrial membrane depolarization and also the release of cytochrome c from mitochondria. Caspase-3 was also activated by SA-liposome treatment. Pretreatment of cells with N-acetylcysteine, a scavenger of reactive oxygen species (ROS), conferred resistance to the induction of the membrane depolarization, cytochrome c release, and caspase-3 activation by SA-liposomes. These results indicated that SA-liposomes caused the apoptosis in RAW264.7 cells through the mitochondrial pathway, and ROS generation was required for this phenomenon. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11488598     DOI: 10.1006/abbi.2001.2458

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  11 in total

1.  Raman microscopy for noninvasive imaging of pharmaceutical nanocarriers: intracellular distribution of cationic liposomes of different composition.

Authors:  T Chernenko; R R Sawant; M Miljkovic; L Quintero; M Diem; V Torchilin
Journal:  Mol Pharm       Date:  2012-03-15       Impact factor: 4.939

2.  Optimizing transfection of primary human umbilical vein endothelial cells using commercially available chemical transfection reagents.

Authors:  Michelle A Hunt; Margaret J Currie; Bridget A Robinson; Gabi U Dachs
Journal:  J Biomol Tech       Date:  2010-07

3.  Counter ions and constituents combination affect DODAX : MO nanocarriers toxicity in vitro and in vivo.

Authors:  Ana Cristina Norberto Oliveira; Marisa Passos Sárria; Pedro Moreira; Joana Fernandes; Lisandra Castro; Ivo Lopes; Manuela Côrte-Real; Artur Cavaco-Paulo; Maria Elisabete Cunha Dias Real Oliveira; Andreia Castro Gomes
Journal:  Toxicol Res (Camb)       Date:  2016-06-13       Impact factor: 3.524

4.  Physicochemical properties of liposomes affecting apoptosis induced by cationic liposomes in macrophages.

Authors:  Shuhei Takano; Yukihiko Aramaki; Seishi Tsuchiya
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

5.  An efficient method for generating poxvirus recombinants in the absence of selection.

Authors:  Amanda D Rice; Stacey A Gray; Yu Li; Inger Damon; Richard W Moyer
Journal:  Viruses       Date:  2011-03       Impact factor: 5.048

6.  Targeted liposomal drug delivery to monocytes and macrophages.

Authors:  Ciara Kelly; Caroline Jefferies; Sally-Ann Cryan
Journal:  J Drug Deliv       Date:  2010-10-26

Review 7.  Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods.

Authors:  Nasir Javaid; Farzana Yasmeen; Sangdun Choi
Journal:  Pharmaceutics       Date:  2019-09-01       Impact factor: 6.321

Review 8.  Immunological and Toxicological Considerations for the Design of Liposomes.

Authors:  Collin T Inglut; Aaron J Sorrin; Thilinie Kuruppu; Shruti Vig; Julia Cicalo; Haroon Ahmad; Huang-Chiao Huang
Journal:  Nanomaterials (Basel)       Date:  2020-01-22       Impact factor: 5.076

9.  Essential Role of Host Double-Stranded DNA Released from Dying Cells by Cationic Liposomes for Mucosal Adjuvanticity.

Authors:  Rui Tada; Akihiro Ohshima; Yuya Tanazawa; Akari Ohmi; Saeko Takahashi; Hiroshi Kiyono; Jun Kunisawa; Yukihiko Aramaki; Yoichi Negishi
Journal:  Vaccines (Basel)       Date:  2019-12-27

10.  Liposomes as a Nanoplatform to Improve the Delivery of Antibiotics into Staphylococcus aureus Biofilms.

Authors:  Magda Ferreira; Sandra N Pinto; Frederico Aires-da-Silva; Ana Bettencourt; Sandra I Aguiar; Maria Manuela Gaspar
Journal:  Pharmaceutics       Date:  2021-03-02       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.